SCHEMBL5034516

SCHEMBL5034516

CCOc1ccc(CC2(C(=O)O)CCCO2)cc1CNC(=O)c1sc(-c2ccc(Cl)cc2)nc1C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 10/20 0.46
PPARD Q03181 2/20 0.46
PPARG P37231 3/20 0.44
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
RAB9A P51151 3/20 0.41
NPC1 O15118 3/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
KMT2A Q03164 1/20 0.41
RELA Q04206 1/20 0.41
THRB P10828 1/20 0.40
CHRM4 P08173 1/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034527 0.93 PPARA (0.47) PPARAPPARDPPARGGAASMN1; SMN2
SCHEMBL5031926 0.87 PPARA (0.44) PPARAPPARDPPARGGAARAB9A
SCHEMBL5032944 0.86 PPARA (0.56) PPARAPPARDPPARGGAASMN1; SMN2
SCHEMBL5034523 0.86 HPGD (0.46) PPARAPPARGGAASMN1; SMN2NPC1
SCHEMBL5032982 0.85 PPARA (0.49) PPARAPPARDPPARGGAASMN1; SMN2
SCHEMBL6427465 0.84 PPARA (0.39) PPARAPPARDPPARGMAPTKDM4E
SCHEMBL6428294 0.81 CYP1A2 (0.45) PPARAPPARGNPC1MAPTMEN1
SCHEMBL5034509 0.81 HDAC1 (0.41) PPARAPPARDPPARGNPC1MEN1
SCHEMBL5037183 0.78 NPC1 (0.45) PPARAPPARDPPARGGAASMN1; SMN2
SCHEMBL5034454 0.78 PPARG (0.40) PPARAPPARDPPARGNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-20050014833-A1 Cyclic compound and ppar agonist EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-20 US disclosed
EP-1452521-A1 CYCLIC COMPOUND AND PPAR AGONIST Eisai Co., Ltd. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014833-A1 Cyclic compound and ppar agonist PPARA, PPARG, PPARD PPARA 1/4885PPARD 3/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.